Gomez-Arbelaez Diego, Ibarra-Sanchez Gabriela, Garcia-Gutierrez Ania, Comanges-Yeboles Alejandra, Ansuategui-Vicente Marina, Gonzalez-Fajardo Jose Antonio
Division of Vascular Surgery, Hospital Universitario 12 de Octubre, Madrid, Spain.
Division of Vascular Surgery, Hospital Universitario 12 de Octubre, Madrid, Spain.
Ann Vasc Surg. 2020 Aug;67:10-13. doi: 10.1016/j.avsg.2020.05.031. Epub 2020 May 29.
COVID-19 may predispose patients to an increased risk of thrombotic complications through various pathophysiological mechanisms. Most of the reports on a high incidence of thrombotic complications are in relation to deep vein thrombosis and pulmonary embolism, while the evidence about arterial thrombosis in patients with COVID-19 is limited. We describe 4 cases of aortic thrombosis and associated ischemic complications in patients with severe SARS-CoV-2 infection.
新型冠状病毒肺炎(COVID-19)可能通过多种病理生理机制使患者发生血栓形成并发症的风险增加。关于血栓形成并发症高发生率的大多数报告都与深静脉血栓形成和肺栓塞有关,而关于COVID-19患者动脉血栓形成的证据有限。我们描述了4例严重严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染患者发生主动脉血栓形成及相关缺血性并发症的病例。